HSBC Holdings’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-16,205
| Closed | -$88K | – | 2752 |
|
|
2025
Q1 | $88K | Sell |
16,205
-107
| -0.7% | -$581 | ﹤0.01% | 2380 |
|
|
2024
Q4 | $55.5K | Sell |
16,312
-7,349
| -31% | -$25K | ﹤0.01% | 2539 |
|
|
2024
Q3 | $67.3K | Sell |
23,661
-315
| -1% | -$896 | ﹤0.01% | 2467 |
|
|
2024
Q2 | $53.5K | Sell |
23,976
-1,084
| -4% | -$2.42K | ﹤0.01% | 2436 |
|
|
2024
Q1 | $55.4K | Buy |
25,060
+14,444
| +136% | +$31.9K | ﹤0.01% | 2509 |
|
|
2023
Q4 | $25.2K | Hold |
10,616
| – | – | ﹤0.01% | 2198 |
|
|
2023
Q3 | $19.8K | Hold |
10,616
| – | – | ﹤0.01% | 2144 |
|
|
2023
Q2 | $27.5K | Hold |
10,616
| – | – | ﹤0.01% | 2064 |
|
|
2023
Q1 | $17.2K | Hold |
10,616
| – | – | ﹤0.01% | 2175 |
|
|
2022
Q4 | $13.5K | Hold |
10,616
| – | – | ﹤0.01% | 2533 |
|
|
2022
Q3 | $17K | Hold |
10,616
| – | – | ﹤0.01% | 2418 |
|
|
2022
Q2 | $16K | Sell |
10,616
-2,474
| -19% | -$3.73K | ﹤0.01% | 2760 |
|
|
2022
Q1 | $34K | Sell |
13,090
-1,302
| -9% | -$3.38K | ﹤0.01% | 2829 |
|
|
2021
Q4 | $42K | Sell |
14,392
-827
| -5% | -$2.41K | ﹤0.01% | 2715 |
|
|
2021
Q3 | $37K | Buy |
+15,219
| New | +$37K | ﹤0.01% | 2463 |
|